← Back to headlines
Seres Therapeutics Reports Q4 GAAP EPS of $0.64, Revenue of $0.78M
Seres Therapeutics announced its GAAP earnings per share for the latest quarter was $0.64, with total revenue reaching $0.78 million.
12 Mar, 19:38 — 12 Mar, 19:38
Sources
Showing 1 of 1 sources
Related Stories
Amazon Cargo Plane Overshoots Runway at Miami Airport
18m ago
Japan’s Foreign Reserves Plunge Record $79.6 Billion After Yen Intervention
1h ago
Record-Breaking White Falcon Fetches 2.1 Million Dirhams at Abu Dhabi Auction
1h ago
China Injects Over $50 Billion Into State Banks and Insurers to Stimulate Growth
1h ago